• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 474-488 of 1,371 results

2057 Exhibit: JSN 2057 Bubley et al, ¿¿¿Eligibility and Response Guidelines for Phas...

Document IPR2016-01332, No. 2057-64 Exhibit - JSN 2057 Bubley et al, ¿¿¿Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen Independent Prostate Cancer (P.T.A.B. Mar. 8, 2017)

cite Cite Document

2137 Exhibit: JSN 2137 BTG Annual Report, 2003

Document IPR2016-01332, No. 2137-132 Exhibit - JSN 2137 BTG Annual Report, 2003 (P.T.A.B. Mar. 8, 2017)

cite Cite Document

1028 Exhibit: Jebelirer

Document IPR2016-01332, No. 1028 Exhibit - Jebelirer (P.T.A.B. Jun. 30, 2016)

cite Cite Document

1025 Exhibit: Harrisons Internal Medicine

Document IPR2016-01332, No. 1025 Exhibit - Harrisons Internal Medicine (P.T.A.B. Jun. 30, 2016)

cite Cite Document

1066 Exhibit: Zytiga Website

Document IPR2016-01332, No. 1066 Exhibit - Zytiga Website (P.T.A.B. Jun. 30, 2016)

cite Cite Document

2017 Exhibit: JSN 2017 Ryan et al, ¿¿¿Phase II Study of Abiraterone in Chemotherap...

Document IPR2016-01332, No. 2017-23 Exhibit - JSN 2017 Ryan et al, ¿¿¿Phase II Study of Abiraterone in Chemotherapy Na¿¿ve Flare Discordant with Serologic Response (P.T.A.B. Mar. 8, 2017)

cite Cite Document

2143 Exhibit: JSN 2143 JJ Q1 2014 Earnings Call Transcript

Document IPR2016-01332, No. 2143-138 Exhibit - JSN 2143 JJ Q1 2014 Earnings Call Transcript (P.T.A.B. Mar. 8, 2017)

cite Cite Document

1009 Exhibit: Ryan 2013

Document IPR2016-01332, No. 1009 Exhibit - Ryan 2013 (P.T.A.B. Jun. 30, 2016)

cite Cite Document

1019 Exhibit: Zytiga Brochure

Document IPR2016-01332, No. 1019 Exhibit - Zytiga Brochure (P.T.A.B. Jun. 30, 2016)

cite Cite Document

1104 Exhibit: Garnick Reply Declaration

Document IPR2016-01332, No. 1104-212 Exhibit - Garnick Reply Declaration (P.T.A.B. Apr. 19, 2017)

cite Cite Document

2063 Exhibit: JSN 2063 Small et al, ¿¿¿Antiandrogen Withdrawal Alone or in Combina...

Document IPR2016-01332, No. 2063-70 Exhibit - JSN 2063 Small et al, ¿¿¿Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen Independent Prostate Cancer Patients A Phase ...

cite Cite Document

2122 Exhibit: JSN 2122 Declaration of Scott Serels, MD, filed on Jan 16, 2017 in Am...

Document IPR2016-01332, No. 2122-118 Exhibit - JSN 2122 Declaration of Scott Serels, MD, filed on Jan 16, 2017 in Amerigen Pharmaceuticals Ltd v Janssen Oncology, Inc, IPR2016 00286 (P.T.A.B. Ma...

cite Cite Document

1151 Exhibit: Hoffman Declaration 51017

Document IPR2016-01332, No. 1151-226 Exhibit - Hoffman Declaration 51017 (P.T.A.B. May. 10, 2017)

cite Cite Document

2184 Exhibit: JSN 2184 Austin and Hux, ¿¿¿A Brief note on overlapping confidence i...

Document IPR2016-01332, No. 2184-218 Exhibit - JSN 2184 Austin and Hux, ¿¿¿A Brief note on overlapping confidence intervals,¿¿¿ J of Vascular Surgery, 361194 195 2002 (P.T.A.B. May. 3, 2017)

cite Cite Document

2159 Exhibit: JSN 2159 Declaration of Alyssa B Monsen

Document IPR2016-01332, No. 2159-154 Exhibit - JSN 2159 Declaration of Alyssa B Monsen (P.T.A.B. Apr. 3, 2017)

cite Cite Document
<< 1 2 3 4 5 ... 32 33 34 35 36 ... >>